| May, 9 | Actemra inhibits joint damage and improves physical function of patients with Rheumatoid Arthritis more.. |
| Apr, 17 | Roche continues solid sales growth in first quarter of 2008 - both divisions significantly outpace their markets more.. |
| Apr, 16 | Actemra approved in Japan to treat patients with rheumatoid arthritis more.. |
| Apr, 15 | Roche fully acquires privately-owned biotech company Piramed more.. |
| Mar, 4 | Roche raises dividend by 35 percent more.. |
| Feb, 29 | Herceptin approved in Japan for early treatment in patients with HER2-positive breast cancer more.. |
| Feb, 23 | FDA grants accelerated approval of Avastin in combination with paclitaxel chemotherapy for first-line treatment of patients with advanced HER2-negative breast cancer more.. |
| Feb, 19 | Roche Completes Tender Offer for Ventana Shares more.. |
| Feb, 13 | Second phase III study of Avastin in 1st line metastatic breast cancer meets its primary endpoint more.. |
| Feb, 8 | Roche purchases shares in tender offer for Ventana more.. |
| Jan, 30 | Annual Media Conference more.. |
| Jan, 30 | Record operating results for Roche again in 2007 more.. |
| Jan, 28 | Avastin receives broad label extension in Europe for the treatment of patients with metastatic colorectal cancer more.. |
| Jan, 25 | MabThera meets study primary endpoint in improving disease symptoms when used as first biologic therapy in patients with rheumatoid arthritis more.. |
| Jan, 25 | MabThera increases the time patients with the most common form of adult leukaemia live without their cancer progressing more.. |
| Jan, 22 | Roche to Acquire Ventana for $89.50 per share more.. |
| Jan, 18 | Roche invests 430 million Swiss francs at sites in Germany and Switzerland more.. |
| Jan, 9 | Roche engages in four additional AIDS Technology Transfers to strengthen local manufacturing in world´s poorest countries more.. |
print this page